Inflammatory biomarkers in the cerebrospinal fluid (CSF) of Parkinson’s disease patients with and without mutations in the GBA gene are at similar levels, and across all patients, higher levels of these markers associate with poorer cognition over time, a study found. TNF-alpha, a pro-inflammatory molecule, showed particular potential as a predictive…
People with physical frailty have a nearly twofold higher risk of developing Parkinson’s disease than those who aren’t frail, according to an analysis of 12-year data from a U.K. study. Being frail and carrying several genetic variants linked to Parkinson’s further enhanced the chances of developing the neurodegenerative disease…
IMAC Holdings and Brain Scientific have agreed to merge to offer solutions that cover the spectrum of care for neurological diseases, starting from diagnosis all the way through to treatment. The collaboration will focus mainly on disease management for people with Parkinson’s disease, Alzheimer’s disease, and…
People with idiopathic Parkinson’s disease have significantly higher blood levels of neurofilament light chain (NfL) — a biomarker of nerve cell damage — than those whose Parkinson’s is associated with mutations in the LRRK2 gene, a study showed. This difference, however, held true only for the early stages of disease,…
Most types of physical exercise can help to ease motor symptoms in adults with Parkinson’s disease and improve their quality of life, according to a review study. “Our review highlights the importance of physical exercise in general, while the exact exercise type may be secondary,” Elke Kalbe, PhD,…
Symbyx Neuro, Symbyx Biome’s red/infrared light therapy helmet, improves motor function in Parkinson’s disease, according to data from a small sham-controlled clinical trial. Parkinson’s “has historically been an intractable, neurodegenerative condition that typically declines with no improvements possible,” Wayne Markman, Symbyx‘s CEO, said in a company…
Scientists are calling for a ban on trichloroethylene (TCE), a common and widely used chemical that’s increasingly linked to multiple health problems, including cancer and Parkinson’s disease. “Through a literature review and seven illustrative cases, we postulate that this ubiquitous chemical is contributing to the global rise of PD…
Interface Systems has awarded Northwestern University student Laura Felix a $5,000 “Tech for Good” scholarship for creating an app that helps caregivers manage falls by Parkinson’s disease patients. Felix is studying computer science and physics at the university and the one-time scholarship is for the 2022-2023 academic year. Interface also…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is calling on adults 60 and older in the U.S. and Canada who do not have Parkinson’s disease to participate in the Smell Test Challenge, which aims to better understand the connection between loss of smell and neurological disease.
Teitur Trophics has raised €28 million (about $29.7 million) to advance its lead candidate, TT-P34, into a Phase 1b clinical trial as a possible treatment for Parkinson’s and other neurodegenerative diseases. “There is a pressing need for new therapies for neurodegenerative diseases which have a detrimental impact on…
Get regular updates to your inbox.
